Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-5 of 5
Keywords: anthracycline
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Stephen Rankin, Caitlin Fountain, Alastair J. Gemmell, Daire Quinn, Alasdair Henderson, John McClure, Sandy Small, Balaji Venugopal, Pamela McKay, Piotr J. Slomka, David Colville, Mark C. Petrie, Giselle C. Meléndez, Ninian N. Lang
Journal:
Clinical Science
Clin Sci (Lond) (2025) 139 (1): 29–41.
Published: 15 January 2025
...Stephen Rankin; Caitlin Fountain; Alastair J. Gemmell; Daire Quinn; Alasdair Henderson; John McClure; Sandy Small; Balaji Venugopal; Pamela McKay; Piotr J. Slomka; David Colville; Mark C. Petrie; Giselle C. Meléndez; Ninian N. Lang Anthracyclines, such as doxorubicin, are important anti-cancer...
Includes: Supplementary data
Articles
In Collection
Cardiovascular-Oncology
Zuzana Pokorná, Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Eduard Jirkovský, Jan Kubeš, Yvona Mazurová, Michaela Adamcová, Magdalena Holečková, Vladimír Palička, Tomáš Šimůnek, Martin Štěrba
Journal:
Clinical Science
Clin Sci (Lond) (2022) 136 (1): 139–161.
Published: 07 January 2022
...Zuzana Pokorná; Petra Kollárová-Brázdová; Olga Lenčová-Popelová; Eduard Jirkovský; Jan Kubeš; Yvona Mazurová; Michaela Adamcová; Magdalena Holečková; Vladimír Palička; Tomáš Šimůnek; Martin Štěrba Angiotensin-converting enzyme inhibitors (ACEis) have been used to treat anthracycline (ANT)-induced...
Includes: Supplementary data
Articles
In Collection
Cardiovascular-Oncology
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (10): 1311–1332.
Published: 28 May 2021
...Anna Narezkina; Hari K. Narayan; Alice E. Zemljic-Harpf Anthracyclines are effective chemotherapeutic agents, commonly used in the treatment of a variety of hematologic malignancies and solid tumors. However, their use is associated with a significant risk of cardiovascular toxicities and may...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2020) 134 (13): 1859–1885.
Published: 17 July 2020
...Keith Dadson; Oscar Calvillo-Argüelles; Paaladinesh Thavendiranathan; Filio Billia Despite the known risk of cardiotoxicity, anthracyclines are widely prescribed chemotherapeutic agents. They are broadly characterized as being a robust effector of cellular apoptosis in rapidly proliferating cells...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2002) 103 (s2002): 272S–275S.
Published: 01 September 2002
...A. ZSÁRY; S. SZÜCS; T. SCHNEIDER; A. ROSTA; P. SÁRMÁN; T. FENYVESI; I. KARÁDI The role of endothelin-1 (ET-1) in certain pathological states is still unclear. We have investigated the effect of anthracyclines (maximum dose, 450mg/m 2 of body surface) on left ventricular systolic and diastolic...